Sort   by:  
 Page size 
UnknownPhase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.
Not available
S-EPMC7325368 | biostudies-literature
UnknownDevelopment and validation of a targeted gene sequencing panel for application to disparate cancers.
Not available
S-EPMC6864073 | biostudies-literature
UnknownClinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Not available
S-EPMC10346130 | biostudies-literature
Sort   by:  
 Page size